DWI in the Differentiation of Malignant and Benign Breast Lesions Presenting with Non-Mass Enhancement on CE-MRI

dc.contributor.authorPerić, Iva
dc.contributor.authorBrkljačić, Boris
dc.contributor.authorTadić, Tade
dc.contributor.authorJerković, Kristian
dc.contributor.authorDolić, Krešimir
dc.contributor.authorBorić, Matija
dc.contributor.authorĆavar, Marija
dc.contributor.departmentFaculty of Medicine
dc.date.accessioned2025-11-20T09:50:19Z
dc.date.available2025-11-20T09:50:19Z
dc.date.issued2025-01
dc.descriptionPublisher Copyright: © 2024 by the authors.en
dc.description.abstractObjectives: This study aimed to investigate whether the apparent diffusion coefficient (ADC) maps values of breast lesions presenting as non-mass enhancement (NME) on MRI could predict benign or malignant pathohistological findings. Materials and Methods: This retrospective single-center study included 136 female patients with NME and corresponding ultrasound correlate and a subsequent ultrasound-guided core needle biopsy. The patients were subdivided into benign or malignant subgroups based on pathology reports, which served as the gold standard. Blinded to the pathological results, two radiologists independently measured the ADC values of the depicted NME using punctate, 10 mm and whole tumor regions of interest (ROIs) wherever applicable. The mean of all measurements was also analyzed and compared with the pathologic subdivision. Results: The sensitivity of whole tumor ROI in detecting benign NME is 91% compared to 74% for 10 mm ROI and 78% for punctate ROI. No significant differences in ADC values were observed when comparing fatty breast tissue and dense breast tissue. Conclusions: There were differences in ADC values between benign and malignant findings using all types of measurements, where the whole tumor ROI was the most sensitive.en
dc.description.versionPeer revieweden
dc.format.extent3005844
dc.format.extent
dc.identifier.citationPerić, I, Brkljačić, B, Tadić, T, Jerković, K, Dolić, K, Borić, M & Ćavar, M 2025, 'DWI in the Differentiation of Malignant and Benign Breast Lesions Presenting with Non-Mass Enhancement on CE-MRI', Cancers, vol. 17, no. 1, 31. https://doi.org/10.3390/cancers17010031en
dc.identifier.doi10.3390/cancers17010031
dc.identifier.issn2072-6694
dc.identifier.other236538849
dc.identifier.other4bc92045-fba3-4563-958f-b4dfb2b89f40
dc.identifier.other85214469277
dc.identifier.urihttps://hdl.handle.net/20.500.11815/7790
dc.language.isoen
dc.relation.ispartofseriesCancers; 17(1)en
dc.relation.urlhttps://www.scopus.com/pages/publications/85214469277en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectADCen
dc.subjectbreasten
dc.subjectbreast canceren
dc.subjectMR diffusionen
dc.subjectNME lesionsen
dc.subjectOncologyen
dc.subjectCancer Researchen
dc.titleDWI in the Differentiation of Malignant and Benign Breast Lesions Presenting with Non-Mass Enhancement on CE-MRIen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
cancers-17-00031-v2.pdf
Stærð:
2.87 MB
Snið:
Adobe Portable Document Format

Undirflokkur